(Press-News.org) Washington, DC – A common virus that can cause coughing and mild diarrhea appears to have a major redemptive quality: the ability to kill cancer. Harnessing that power, researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, are conducting a clinical trial to see if the virus can target and kill certain tumor types.
By the age of five, most people have been exposed to the virus, called reovirus. For some, it can trigger brief episodes of coughing or diarrhea while many other don't develop any symptoms. The body simply overpowers the virus. But what scientists have discovered is that the virus grows like gangbusters inside tumor cells with a specific malfunction that leads to tumor growth. That finding led researchers to ask: Is it possible to use the virus as a treatment?
At Lombardi, researchers are collaborating with other institutions to look for an answer by conducting a phase II clinical trial for people with advanced or recurrent non-small cell lung cancer with a specific tumor profile.
"With reovirus, we're able to accentuate the positive and attenuate the negative," says the study's lead investigator at Lombardi, Deepa Subramaniam, MD, interim-chief of the Thoracic Medical Oncology Program. In other words, researchers have genetically altered the virus so that it won't replicate in a healthy cell (attenuated), which is what makes a person sick. "What's left is a virus in search of a host, and reovirus loves the environment inside a specific kind of cancer cell," explains Subramaniam.
That specific kind of cancer cell is one with malfunctioning machinery called KRAS or EGFR mutation.
"These mutations leave the cancer vulnerable to a viral take-over. Once it's in, the reovirus exploits the cell's machinery to drive its own replication. As a result, the cell is filled with virus particles causing it to literally explode."
Volunteers in the clinical trial will receive reovirus (REOLYSIN®) in addition to paclitaxel and carboplatin. The physicians will watch to see if the cancer shrinks while also seeing if this combination of drugs causes serious side effects.
"This is a subset of cancer where we haven't had many successes in terms of finding drugs that extend life after diagnosis," says Subramaniam. "This trial represents an attempt to seek and destroy cancer by choosing a treatment based on specific tumor characteristics. Preliminary data from the study should come quickly."
Researchers are also studying the effect of reovirus in other cancer types.
###
Patients interested in learning about this or any other clinical trial should call 202-444-4000.
This study is sponsored by Oncolytics Biotech Inc., maker of REOLYSIN. Subramaniam reports no potential financial interest.
About Lombardi Comprehensive Cancer Center
The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university's sponsored research funding.
END
Aurora, Colo. (Oct. 19, 2010)— Estrogen therapy used by menopausal women causes a type of ovarian cancer to grow five times faster, according to a new study by researchers at the University of Colorado Cancer Center.
Menopausal estrogen replacement therapy (ERT) also significantly increases the likelihood of the cancer metastasizing to the lymph nodes, according to the study, which will be published in the Nov. 1 issue of Cancer Research. The study was released online Oct. 19, 2010. Cancer Research, published by the American Association for Cancer Research, is the world's ...
As Earth's climate warms, species are expected to shift their geographical ranges away from the equator or to higher elevations.
While scientists have documented such shifts for many plants and animals, the ranges of others seem stable.
When species respond in different ways to the same amount of warming, it becomes more difficult for ecologists to predict future biological effects of climate change--and to plan for these effects.
In a study published this week in the journal Nature, University of Wyoming ecologist Daniel Doak and Duke University ecologist William ...
Researchers at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal have identified a new mechanism controlling the transmission of an abnormal signal at the origin of several cancers. In an article published in the journal Cell, Marc Therrien's team explains the recent discovery of a protein complex that controls the RAS/MAPK signalling pathway, responsible for some of the deadliest cancers, including pancreatic, colon and lung cancers, and melanomas. This regulating mechanism could prove to be a promising therapeutic target for the ...
Three NASA satellites are keeping tabs on Typhoon Megi and noticed that it was strengthening in the South China Sea today, but increasing wind shear may again weaken the system over the next couple of days.
NASA's TRMM, CloudSat and Aqua satellite captured images of Megi's clouds, rainfall and eye as they passed over the storm and saw clouds higher than 9 miles filled with ice, creating heavy rainfall.
The Tropical Rainfall Measuring Mission (TRMM) satellite passed over Typhoon Megi from its vantage point in space on October 18 at 2321 UTC (7:31 p.m. EDT) and saw that ...
The GOES-13 satellite keeps a continuous eye over the eastern U.S., the Caribbean Sea, Gulf of Mexico and Atlantic Ocean, and noticed that System 99L is much better organized today, October 20, hinting that it could become a tropical depression later today.
At 8 a.m. EDT on Wednesday, October 20, System 99L, a low pressure system about 150 miles southwest of Grand Cayman appears to be getting organized as it drifts eastward in the Caribbean Sea.
System 99L is showing more organization than it did yesterday, despite strong upper-level winds that are currently inhibiting ...
Princeton computer scientists have developed a new way of tracing the origins and spread of ideas, a technique that could make it easier to gauge the influence of notable scholarly papers, buzz-generating news stories and other information sources.
The method relies on computer algorithms to analyze how language morphs over time within a group of documents -- whether they are research papers on quantum physics or blog posts about politics -- and to determine which documents were the most influential.
"The point is being able to manage the explosion of information made ...
Magicians rely on misdirection—drawing attention to one place while they're carrying out their tricky business somewhere else. It seems like people with autism should be less susceptible to such social manipulation. But a new study in the U.K. finds that people with autism spectrum disorder are actually more likely to be taken in by the vanishing ball trick, where a magician pretends to throw a ball in the air but actually hides it in his hand.
In the vanishing-ball illusion, a magician throws a ball in the air a few times. On the last throw, he merely pretends to throw ...
Conventional wisdom has long been negative on Africa. Historically, it has been seen as a failing continent, plagued by deep-rooted problems — poverty, corruption, war, and disease. But after four decades of relative stagnation, Africa has been growing rapidly. Since the 1990s, many African countries have seen economic and political improvements, more transparent elections, increased democracy and freedom of press. But these successes are not well understood.
In 2007, the National Bureau of Economic Research (NBER), the leading nonprofit economics research organization ...
WASHINGTON, Oct. 20 -- Scientists and engineers from around the world will gather on the shores of Lake Ontario in Rochester, N.Y. next week to discuss some of the latest breakthroughs in lasers and optics and their applications to cutting-edge science, the development of new materials, and medicine.
Journalists are invited to Frontiers in Optics (FiO) 2010/Laser Science XXVI -- the 94th annual meeting of the Optical Society (OSA), which is being held together with the annual meeting of the American Physical Society (APS) Division of Laser Science at the Rochester Riverside ...
CORVALLIS, Ore. – Severe burn injuries in children have been shown to rapidly deplete the levels of vitamin E in their body's adipose, or fat tissues, a new clinical study has found.
Stored levels of this important antioxidant were reduced more in a few weeks than might normally be possible in years.
An analysis of eight children with third-degree burns over much of their body found they lost almost half of their stored vitamin E in three weeks, even though they were being given about 150 percent of the recommended daily allowance of vitamin E and other nutrients in ...
